Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ERP, DIV

Dolby Laboratories Reports Second Quarter 2024 Financial Results


SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2024.

"Our second quarter results were in line with our expectations," said Kevin Yeaman, President and CEO, Dolby Laboratories. "Dolby Atmos and Dolby Vision content is expanding across movies, TV, sports, music and more, driving more consumer device adoption and bringing Dolby to more people worldwide."

Second Quarter Fiscal 2024 Financial Highlights

A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

Dividend

Today, Dolby announced a cash dividend of $0.30 per share of Class A and Class B common stock, payable on May 22, 2024, to stockholders of record as of the close of business on May 14, 2024.

Financial Outlook

Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the second quarter of fiscal 2024, to be filed on or around the date hereof.

Dolby is providing the following estimates for its third quarter of fiscal 2024:

Dolby is providing the following estimates for the full year of fiscal 2024:

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss second quarter fiscal 2024 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 2, 2024. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, May 2, 2024, until 8:59 p.m. PT (11:59 p.m. ET) on Tuesday, May 7, 2024 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the third quarter of fiscal 2024 and full year fiscal 2024, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee? pricing pressures? risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage? the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries? changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements? Dolby's ability to develop, maintain, and strengthen relationships with industry participants? Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets? competitive risks? risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights? risks associated with the health of the motion picture and cinema industries generally, including the potential impacts of the recent strikes by the WGA and SAG-AFTRA? Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings? risks associated with acquiring and successfully integrating businesses or technologies? and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.

 

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)



Fiscal Quarter Ended


Fiscal Year-To-Date Ended


March 29,
2024

March 31,
2023


March 29,
2024

March 31,
2023

Revenue:






Licensing

$                338,240

$                351,608


$                632,007

$                659,619

Products and services

26,283

24,283


48,090

51,193

Total revenue

364,523

375,891


680,097

710,812







Cost of revenue:






Cost of licensing

15,318

21,365


31,054

34,724

Cost of products and services

23,459

19,684


39,783

40,775

Total cost of revenue

38,777

41,049


70,837

75,499







Gross profit

325,746

334,842


609,260

635,313







Operating expenses:






Research and development

62,493

67,951


129,526

132,401

Sales and marketing

90,038

95,695


169,041

177,900

General and administrative

66,742

61,939


131,908

121,911

Restructuring charges/(credits)

(2,495)

33


3,596

(211)

Total operating expenses

216,778

225,618


434,071

432,001







Operating income

108,968

109,224


175,189

203,312







Other income/(expense):






Interest income/(expense), net

8,597

6,807


17,784

11,604

Other income, net

4,183

1,250


9,608

2,347

Total other income

12,780

8,057


27,392

13,951







Income before income taxes

121,748

117,281


202,581

217,263

Provision for income taxes

(23,534)

(21,398)


(36,786)

(41,932)

Net income including noncontrolling interest

98,214

95,883


165,795

175,331

Less: net income attributable to noncontrolling interest

(384)

(187)


(984)

(260)

Net income attributable to Dolby Laboratories, Inc.

$                  97,830

$                  95,696


$                164,811

$                175,071







Net income per share:






Basic

$                      1.02

$                      1.00


$                      1.72

$                      1.83

Diluted

$                      1.01

$                      0.98


$                      1.69

$                      1.80

Weighted-average shares outstanding:






Basic

95,718

95,820


95,547

95,862

Diluted

96,856

97,298


97,397

97,392

 

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)



March 29,
2024

September 29,
2023

ASSETS



Current assets:



Cash and cash equivalents

$                709,535

$                745,364

Restricted cash

114,821

72,602

Short-term investments

115,863

139,148

Accounts receivable, net

282,131

262,245

Contract assets, net

243,170

182,130

Inventories, net

35,797

35,623

Prepaid expenses and other current assets

50,421

50,692

Total current assets

1,551,738

1,487,804

Long-term investments

127,973

97,812

Property, plant, and equipment, net

481,492

481,581

Operating lease right-of-use assets

43,057

40,199

Goodwill and intangible assets, net

560,801

575,836

Deferred taxes

208,494

201,860

Other non-current assets

71,173

94,674

Total assets

$             3,044,728

$             2,979,766




LIABILITIES AND STOCKHOLDERS' EQUITY



Current liabilities:



Accounts payable

$                  19,727

$                  20,925

Accrued liabilities

362,883

351,399

Income taxes payable

8,384

4,769

Contract liabilities

37,702

31,505

Operating lease liabilities

14,206

13,628

Total current liabilities

442,902

422,226

Non-current contract liabilities

36,453

39,997

Non-current operating lease liabilities

37,711

37,020

Other non-current liabilities

89,975

108,339

Total liabilities

607,041

607,582




Stockholders' equity:



Class A common stock

53

53

Class B common stock

41

41

Retained earnings

2,449,876

2,391,990

Accumulated other comprehensive loss

(29,068)

(36,984)

Total stockholders' equity ? Dolby Laboratories, Inc.

2,420,902

2,355,100

Noncontrolling interest

16,785

17,084

Total stockholders' equity

2,437,687

2,372,184

Total liabilities and stockholders' equity

$             3,044,728

$             2,979,766

 

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)



Fiscal Year-To-Date Ended


March 29,
2024

March 31,
2023

Operating activities:



Net income including noncontrolling interest

$                165,795

$                175,331

Adjustments to reconcile net income to net cash provided by operating activities:



Depreciation and amortization

35,890

40,388

Stock-based compensation

60,809

61,067

Amortization of operating lease right-of-use assets

5,847

6,565

Amortization of premium on investments

(1,757)

37

Benefit from credit losses

(1,454)

(2,072)

Deferred income taxes

(6,779)

(19,544)

Other non-cash items affecting net income

(2,500)

(4,417)

Changes in operating assets and liabilities:



Accounts receivable, net

(18,509)

(37,769)

Contract assets, net

(61,008)

(99,162)

Inventories

(7,836)

(4,728)

Operating lease right-of-use assets

(7,848)

(2,643)

Prepaid expenses and other assets

33,527

12,943

Accounts payable and accrued liabilities

3,923

21,609

Income taxes, net

5,215

17,370

Contract liabilities

2,651

3,852

Operating lease liabilities

1,028

(5,415)

Other non-current liabilities

(17,176)

(2,475)

Net cash provided by operating activities

189,818

160,937




Investing activities:



Purchases of marketable securities

(104,135)

(80,561)

Proceeds from sales of marketable securities

4,451

52,345

Proceeds from maturities of marketable securities

97,459

94,843

Purchases of property, plant, and equipment

(15,015)

(14,741)

Net cash provided by (used in) investing activities

(17,240)

51,886




Financing activities:



Proceeds from issuance of common stock

29,345

21,394

Repurchase of common stock

(104,999)

(99,276)

Payment of cash dividend

(57,268)

(51,741)

Distribution to noncontrolling interest

(1,047)

(266)

Shares repurchased for tax withholdings on vesting of restricted stock

(36,054)

(26,800)

Equity issued in connection with business combination

722

?

Payment of deferred consideration for prior business combinations

?

(500)

Net cash used in financing activities

(169,301)

(157,189)




Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

3,113

9,415

Net increase/(decrease) in cash, cash equivalents, and restricted cash

6,390

65,049

Cash, cash equivalents, and restricted cash at beginning of period

817,966

628,371

Cash, cash equivalents, and restricted cash at end of period

$                824,356

$                693,420

 

GAAP to Non-GAAP Reconciliations

(unaudited)








The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the second quarter and year-to-date periods ended March 29, 2024 and March 31, 2023:








Net income:


Fiscal Quarter Ended


Fiscal Year-To-Date Ended

(in thousands)


March 29,
2024

March 31,
2023


March 29,
2024

March 31,
2023

GAAP net income attributable to Dolby Laboratories, Inc.


$             97,830

$             95,696


$            164,811

$        175,071

Stock-based compensation (1)


28,915

29,827


60,809

61,067

Amortization of acquisition-related intangibles (2)


3,031

2,372


6,155

3,719

Restructuring charges/(credits)


(2,495)

33


3,596

(211)

Income tax adjustments


(4,091)

(5,367)


(13,541)

(9,655)

Non-GAAP net income attributable to Dolby Laboratories, Inc.


$            123,190

$            122,561


$            221,830

$        229,991








(1) Stock-based compensation included in above line items:







Cost of products and services


$                  356

$                  432


$                  766

$               934

Research and development


8,949

9,473


19,055

20,148

Sales and marketing


9,927

10,275


20,408

21,003

General and administrative


9,683

9,647


20,580

18,982








(2) Amortization of acquisition-related intangibles included in above line items:







Cost of licensing


$                   (15)

$                    62


$                    47

$               123

Cost of products and services


524

866


1,058

1,733

Research and development


?

126


?

254

Sales and marketing


650

805


1,306

1,609

General and administrative


1,872

513


3,744

?








Diluted earnings per share:


Fiscal Quarter Ended


Fiscal Year-To-Date Ended



March 29,
2024

March 31,
2023


March 29,
2024

March 31,
2023

GAAP diluted earnings per share


$                 1.01

$                 0.98


$                 1.69

$              1.80

Stock-based compensation


0.30

0.31


0.63

0.63

Amortization of acquisition-related intangibles


0.03

0.02


0.06

0.03

Restructuring charges


(0.03)

?


0.04

?

Income tax adjustments


(0.04)

(0.05)


(0.14)

(0.10)

Non-GAAP diluted earnings per share


$                 1.27

$                 1.26


$                 2.28

$              2.36















Weighted-average shares outstanding - diluted (in thousands)


96,856

97,298


97,397

97,392








The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the third quarter of fiscal 2024 and full year fiscal 2024 included in this release:








Operating expenses (in millions):



Q3 2024



Fiscal 2024

GAAP operating expenses (low - high end of range)



$215 - $225



$885 - $895

Stock-based compensation



(32)



(128)

Amortization of acquisition-related intangibles



(3)



(13)

Restructuring charges



?



(4)

Non-GAAP operating expenses (low - high end of range)



$180 - $190



$740 - $750








Operating margin:





Fiscal 2024

GAAP operating margin






20% +/-

Stock-based compensation






10 %

Amortization of acquisition-related intangibles






1 %

Restructuring charges






1 %

Non-GAAP operating margin






32% +/-






















Effective tax rate:






Q3 2024

GAAP effective tax rate






24 %

Stock-based compensation (low - high end of range)






(2%) - 0%

Amortization of acquisition-related intangibles (low - high end of range)






(1%) - 0%

Non-GAAP effective tax rate






21 %








Diluted earnings per share:


Q3 2024


Fiscal 2024



Low

High


Low

High

GAAP diluted earnings per share


$                 0.21

$                 0.36


$                 2.30

$              2.45

Stock-based compensation


0.33

0.33


1.30

1.30

Amortization of acquisition-related intangibles


0.03

0.03


0.14

0.14

Restructuring charges


?

?


0.04

0.04

Income tax adjustments


(0.06)

(0.06)


(0.18)

(0.18)

Non-GAAP diluted earnings per share


$                 0.51

$                 0.66


$                 3.60

$              3.75








Weighted-average shares outstanding - diluted (in thousands)


97,300

97,300


97,600

97,600

                                                               

Investor Contact:
Peter Goldmacher
415-254-7415
[email protected] 

Media Contact:
Rachel Lowery
[email protected] 

 

SOURCE Dolby Laboratories, Inc.


These press releases may also interest you

at 02:01
Following the HFM European Performance awards evening held at London's iconic Victoria and Albert Museum last Thursday 10th October, the team at Headstart Advisers limited are pleased to announce that the Headstart Fund of Funds won the long term...

at 02:00
In response to the increased sophistication and prevalence of cyber threats, and board mandates on operational resilience, Broadridge Financial Solutions, Inc. has launched a range of enhanced services and solution capabilities for international...

at 01:48
Strategic highlights ? solid progress on both strategic and operational priorities  Increased momentum in programmable networks, mobile network contract wins in multiple markets.  Global supply of Network APIs secured with JV agreed between leading...

at 01:29
DBN Group, a leading high-tech agricultural enterprise, has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companies. This initiative seeks to establish an open innovation and...

at 01:00
Rockwell Automation, Inc. , the world's largest company dedicated to industrial automation and digital transformation, today announced it has signed an agreement with Taurob (Dietsmann Group) to provide a holistic robotic solution that would enable...

at 00:22
CoinEx Research has released its comprehensive report on the cryptocurrency market for September 2024. This month marked a pivotal month for remarkable rebound fueled by significant policy shifts and technological advancements. Federal Reserve's 50...



News published on and distributed by: